Dr. Vedant Kabra, who is the Principal Director for Surgical Oncology at Fortis Memorial Research Institute, Gurgaon, India, is one of the leading oncologists in the country.
He is a well-known expert in surgical oncology, this being the result of his comprehensive training and practical experience.
With his MBBS, Dr Kabra underwent further studies to acquire a Master’s in Surgery and subsequently, specialize in oncology.
He polished his skills and also increased his knowledge by obtaining fellowships and certifications from renowned institutions all over the world, which include a Fellowship in Surgical Oncology.
Dr Kabra’s professional competence spans a wide spectrum of oncologic surgeries, including head and neck, breast, thoracic, gastrointestinal, and gynaecological cancers.
He is widely known for his remarkable skills in surgery, especially in his patient-centred approach, which dramatically improves the results of the treatment.
His goal of oncology contains more than just surgery, as he is actively involved in research and education, which in turn, leads to the discovery of new cancer treatment methods and training of future oncologists.
Ranked No. 2 in Delhi NCR’s Best Private Hospitals by The Week Magazine Survey, 2019 India's 1st robot-assisted Joint Replacement Surgery JCI & NABH Accredited Hospital.
Founded in 2013, Fortis Memorial Research Institute (FMRI) Hospital Gurgaon is a multi-super specialty hospital equipped with world-class infrastructure and highly qualified medical professionals, including super sub-specialists
Achieved rank 2 in a global study of ‘30 Most Technologically Advanced Hospitals in the World'
Top specialties of the hospital include cardiac sciences, gastroenterology and hepatobiliary sciences, hematology, nephrology, neurology, oncology
A flagship hospital of the extended Fortis network of hospitals, FMRI has set new benchmarks as a leading adopter of new technology and excellence in clinical care
At a national level, FMRI operates the second-largest program for bone marrow transplants, performing over 200 transplants in the last year
International patients comprise approximately 22 percent of the total patient volume, and can avail of dedicated features such as translators, prayer rooms, money exchange, and international patient lounges
Fortis Memorial Research Institute is accredited by the Joint Commission International (JCI), the National Accreditation Board for Hospitals & Healthcare Providers (NABH), and the National Accreditation Board for Testing and Calibration Laboratories (NABL)
